Question 1

What is Biodexa Pharmaceticals (BDRX) stock price today?

Accepted Answer

Biodexa Pharmaceticals (BDRX) currently trades at $3.14 per share. The stock has a market capitalization of $2.14M and a P/E ratio of —x.

Question 2

Is BDRX stock a buy, sell, or hold in 2026?

Accepted Answer

Based on WallStSmart's proprietary analysis, Biodexa Pharmaceticals has a Smart Value Score of 34/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is 3/9 and Altman Z-Score is -15.01.

Question 3

What is Biodexa Pharmaceticals's revenue and earnings?

Accepted Answer

Biodexa Pharmaceticals has trailing twelve-month (TTM) revenue of $83000.00 with profit margins of 0.00%. Earnings per share (EPS) is $-3.38.

Question 4

Is Biodexa Pharmaceticals financially healthy?

Accepted Answer

Biodexa Pharmaceticals's Piotroski F-Score is 3/9 (weak financial health). The Altman Z-Score of -15.01 places it in the distress.

Metric	2022	2023	2024	2025	TTM
Revenue	$699000.00	$381000.00	$0.00	$0.00	$83000.00
Net income	$-7.66M	$-7.08M	$-5.73M	$-6.24M	$-2.56M
EPS	—	—	—	—	$-3.38
Free cash flow	$-7.11M	$-7.09M	$-13.04M	$-5.40M	$-2.33M
Profit margin	-1,095.28%	-1,858.01%	—	—	—

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
BDRX	$2.14M	34	3.7	3.0	5.0	6.5	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Biodexa Pharmaceticals

WallStSmart proprietary scores

Price targets

Price chart

X-Ray snapshot

Key financials

Peer comparison

Smart narrative

Frequently asked questions

Company info

Quick metrics

Performance

Compare